Keywords: Strides Arcolab, Agila Specialties, Pfizer, Novartis, Hospira, Astellas, Investigational drug supply, Investment, Injectable drugs

News briefs: Drug majors eyeing Strides Arcolab unit; Astellas invests in oncology facility

Article | 20 August 2012

Leading drug multinationals, including global behemoth Pfizer (NYSE: PFE) and Swiss major Novartis (NOVN: VX) are reportedly considering acquiring  ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in